Alcohol was the cause of nearly five million deaths globally in 2010, an increase of over one million deaths recorded ten years earlier. It was the leading risk factor for disease in southern sub-Saharan Africa (SSA). Several factors account for the increasing harm associated with alcohol in Africa among which are the availability of a wide variety of alcoholic beverages, rising urban populations, more disposable income to purchase alcohol, and unrestrained marketing and promotion of alcohol. Using a variety of strategies, producers of alcohol target young people and women with aspirational messages and other exhortations in an onslaught of marketing and promotion. The author argues that missing in the discussion on alcohol in most African countries is the understanding that alcohol marketing is not an ordinary economic activity and that the business of alcohol (an addictive substance with high potential for harm) can subvert individual rights and democratic principles. This paper discusses these issues with particular attention to the harms caused by alcohol (to drinkers and non-drinkers alike), the potential for far-reaching harms to individuals and the society at large if the present scenario continues, and how these harms can be averted or minimized with the implementation of evidence-based policies.
Health equity in economic and trade policies
Across Africa, China has become known as the agent of mass construction, bartering infrastructural development – chiefly mining-specific – for long-term access to strategic resources. Through this mechanism, Ghanaian cocoa, Gabonese iron and Congolese oil have been swapped for construction of dams (Bui, Poubara, and River Dam), allowing Chinese corporations such as Sinohydro to capture Africa's hydropower market. The 'barter system' enables China to export goods and labour and to 'import' recycled project capital and African resources. In the process, the author of this article argues that China has activated the same 'Western' capitalist vehicles of engagement but with one noticeable difference: prior to Beijing's entrance, just 4% of foreign direct investment (FDI) was earmarked for infrastructure. China has constructed stadiums across the continent, as well as buildings and special economic zones. Though Zambia was pegged as the third largest recipient of Chinese investment in Africa, Zambian labour unions appear apprehensive about Chinese FDI as the means of national development, stating that Chinese FDI has had modest impact on national development, with overall negative impacts on the labour market. In Zambian mines, the bulk of the work is reported to be subcontracted to Chinese workers and companies, leading to complaint of displacement of local workers.
The Alternative Mining Indaba (AMI) started in 2010 with a small group of approximately 40 participants lead by Faith Based Organisations. It intended to create space for communities living in and around mines affected by and left out of key discussions of extractive industries in Africa. The theme for the 2018 AMI was: “Making Natural Resources Work for the People: Towards Just Legal, Policy and Institutional Reform”. The Thematic issues for discussion included: human rights defenders; the curse of natural resource policies; gender and legal reforms; the independent problem solving mechanism; policies and laws that facilitate the benefit sharing for local people and faith and the extractives sector. The meeting gathered representatives of over 400 members of faith-based organisations, civil society organisations, community-based organisations, pan-African networks and organisations, labour movements, women movements, human rights activists, media, students from African countries and international partners on February 5 – 7, 2018 in Cape Town. The AMI site provides presentations and proceedings from the indaba.
On the 6th of December 2006 the WTO General Counsel agreed to amend the TRIPs Agreement by permanently incorporating an earlier waiver. Paul Kruger, a TRALAC researcher, comments on the decision to "Amendment to the TRIPs Agreement: The issue of universal access".
The paper delivers an analytical framework for the assessments of this new sector of international trade which takes into account both the ‘general welfare aspects’ and the effects for the achievement of general ‘health system goals’. Trade in Health Services is split up according to the four modes of service supply introduced by the General Agreement of Trade in Services (GATS). For each mode examples are enclosed and the current level of trade is analysed. It is also examined what are the major obstacles for trade in these modes and what liberalization perspectives are given. The subsequent discussion and plausibility considerations of how each mode may contribute to improve efficiency as well as equity in national health systems is a systematic starting point for further research. It provides a first insight in how trade in Health Services could help to overcome resource constraints in national health systems as well as allude to the potential risks of which sight shouldn’t be lost.
Non-communicable diseases (NCDs) are the leading cause of death globally, killing more people each year than all other causes combined. Furthermore, behavioural risk factors for NCDs fall increasingly on poorer people within all countries, mirroring the underlying socio-economic determinants. The need for prevention efforts through well-planned, cost-effective and feasible interventions across all levels of society is therefore obvious, the authors of this paper argue. The workplace is argued to provide an important setting for ecological models that ensure the both the policies and the environments that enable health.
This paper argues that Uganda needs a secure and predictable trading regime with their main export market in the EU. This makes an EPA essential. The possible shocks that normally come with any change have been well anticipated and safeguards built into the negotiations and ultimately the EPA. Safeguards include for example designation of certain products as sensitive and therefore not eligible for tariff reduction (liberalization) when imported into Uganda, longer (up to twenty five years) tariff phase-down/reduction periods for products where tariffs may be reduced, and reservation of the right to restrict imports should they threaten to cause injury to domestic industry.
In this interview, Alhaji Mohamed Daramy affirms his support for economic partnership agreements (EPAs) but warns that the required fiscal reforms will not come without an upfront cost, and he believes an EPA regional fund should be created to support this process, to which the European Union (EU) should contribute. He argues for a five-year transition period after the signature of an EPA, after which an efficient indirect taxation system should be put in place. Within this period, ECOWAS will aim to move some activities from the informal sector to the formal economy. The certainty and sustainability of financing ECOWAS activities will then be reviewed at this point.
Thousands of people living with AIDS in the Democratic Republic of Congo (DRC) are going without treatment while the production line at a modern antiretroviral (ARV) factory in the east of the country lies largely idle. Pharmakina has produced generic ARVs since April 2005 in the eastern province of Bukavu, the first pharmaceutical firm to do so in central Africa, but it is now forced to await approval from the World Health Organization (WHO).
In this report, the author found that proprietary rights on “influenza genetic sequences and the proteins they encode, used in vaccines,” get in the way of developing countries’ access to medicines. The study shows a sharp rise in patent applications in this area since 2006, shortly after the outbreak of H5N1 in late 2005. The study lists a series of examples of patent applications, such as Baxter International, for the production of influenza vaccines, published in July 2010. This patent application includes animal and human H5N1 types from China, Vietnam, Indonesia, Thailand, Cambodia, Turkey, and Singapore. According to the author, developing countries “collect and share influenza viruses with WHO’s Global Influenza Surveillance Network with the understanding that those viruses are to be used for public health.” However, proprietary claims can prevent access to technology and products produced with a given technology, he said.